<DOC>
	<DOCNO>NCT01498900</DOCNO>
	<brief_summary>This study conduct Africa Asia . The aim study evaluate efficacy , safety convenience use repaglinide ( NovoNorm® ) type 2 diabetes management routine clinical practice .</brief_summary>
	<brief_title>An Observational Study Evaluating Efficacy , Safety Convenience NovoNorm® Treatment Type 2 Diabetes Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<criteria>Type 2 diabetes Newly diagnose adequately control current therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>